Clearside BiomedicalCLSDQ

13F holders, Q4 2025 (December 31)
1holders −23
1new positions
24sold out
$0.70avg. 13F price*

At the end of Q4 2025, 1 institutions reported holding Clearside Biomedical Inc. (CLSDQ) in their 13F filings, down 23 from Q3 2025. 1 opened new positions and 24 sold out. The largest holder was DRW Securities, LLC ($19K).

Company
Clearside Biomedical Inc.
CUSIP
185063203
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q3 2025: 24Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions1$19K
Exits24$1.7M

All 13F filers, Q3 2025 → Q4 2025: 27,136 shares bought and 437,636 shares sold, net −410,500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

DRW Securities, LLC 0.00% New 27,136 $19K

"% of holder's portfolio" is CLSDQ's weight in each manager's 13F, not the share of Clearside Biomedical Inc. the manager owns.